Diphenhydramine Hydrochloride Injection, Solution
Product Images NDC 25021-481

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hydrochloride (NDC 25021-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dip0o 0000 01)

Chemical structure diagram of diphenhydramine hydrochloride, showing the molecular arrangement of the active ingredient in the product.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dip0o 0000 02)

Label for Diphenhydramine Hydrochloride Injection, USP 50 mg/mL, a high potency solution for intramuscular or slow intravenous use. The 1 mL single-dose vial is manufactured for Sagent Pharmaceuticals, Schaumburg, IL, and made in India. The label includes NDC 25021-481-01 and usage instructions to protect from light and discard unused portion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.